We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nyer Medical Grp. (MM) | NASDAQ:NYER | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.83 | 0 | 01:00:00 |
Registration No. 333-66554
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
to
FORM S-3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
NYER MEDICAL GROUP, INC.
(Exact Name of Registrant as Specified in Its Charter)
Florida |
|
04-0469607 |
(State or Other Jurisdiction of Incorporation or Organization) |
|
(I.R.S. Employer Identification No.) |
13 Water Street
Holliston, Massachusetts 01746
(508) 429-8506
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Mark Dumouchel, President
Nyer Medical Group, Inc.
13 Water Street
Holliston, Massachusetts 01746
(508) 429-8506
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copy to :
Howard E. Berkenblit, Esq.
Sullivan & Worcester LLP
One Post Office Square
Boston, Massachusetts 02109
(617) 338-2800
Approximate date of commencement of proposed sale to the public: Not applicable.
If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. o
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. o
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. o
If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. o
DEREGISTRATION OF UNSOLD SHARES OF COMMON STOCK
On August 2, 2001, Nyer Medical Group, Inc. (the Company) filed a Registration Statement on Form S-3 (Registration No. 333-66554) (the Registration Statement) for resales of an aggregate of 15,873 shares of common stock, par value $.0001 per share, of the Company. This Post-Effective Amendment No. 1 is being filed by the Company pursuant to the Companys undertaking in accordance with the Registration Statement to deregister all 15,873 shares of common stock registered pursuant to the Registration Statement, or such lesser portion that have not been sold or transferred pursuant to the Registration Statement as of the date this Post-Effective Amendment No. 1 is filed. The contractual obligations between the Company and the selling securityholder named in the Registration Statement requiring the Registration Statement to remain effective have expired by their terms.
2
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3, and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Holliston, Commonwealth of Massachusetts, as of the 17 th day of September, 2009.
|
Nyer Medical Group, Inc. |
||
|
|
||
|
|
||
|
By: |
/s/ Mark Dumouchel |
|
|
|
Name: |
Mark Dumouchel |
|
|
Title: |
President and Chief Executive Officer |
Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
/s/ David Dumouchel |
|
Director |
|
September 17, 2009 |
David Dumouchel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Robert J. Landis |
|
Director |
|
September 17, 2009 |
Robert J. Landis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ James Schweiger |
|
Director |
|
September 17, 2009 |
James Schweiger |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Gerald Weston |
|
Director |
|
September 17, 2009 |
Gerald Weston |
|
|
|
|
3
1 Year Nyer Medical Chart |
1 Month Nyer Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions